You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a “common language” for the new arena of cancer treatment

Article metrics

Article menu

Download PDFPDF

Commentary
Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a “common language” for the new arena of cancer treatment

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2025

AbstractFullPdf
Dec 2019110
Jan 202014140
Feb 202011117
Mar 202011111
Apr 2020440
May 202014141
Jun 202011111
Jul 202011112
Aug 2020771
Sep 202031311
Oct 202032314
Nov 202011111
Dec 202013132
Jan 202115154
Feb 202113148
Mar 202113133
Apr 2021994
May 202119193
Jun 202119193
Jul 202115153
Aug 202113131
Sep 2021772
Oct 202111115
Nov 202114144
Dec 202113131
Jan 202210110
Feb 2022771
Mar 202219192
Apr 202216172
May 202225252
Jun 202221211
Jul 202221222
Aug 202221215
Sep 202220200
Oct 202216162
Nov 2022176212
Dec 202224241
Jan 202320200
Feb 202320200
Mar 202311112
Apr 2023441
May 202314143
Jun 202315153
Jul 2023232323
Aug 20239934
Sep 20238834
Oct 2023161636
Nov 2023882
Dec 202314143
Jan 2024891
Feb 202425251
Mar 202411115
Apr 202414142
May 202419194
Jun 202431328
Jul 202431329
Aug 202416184
Sep 202414145
Oct 202412126
Nov 202424263
Dec 202429290
Jan 202521214
Feb 202518183
Mar 202544443
Apr 202539398
May 202519205
Jun 202513133
Jul 2025110
Sep 2025220
Total11021158307